HomeTagsPhase 3 Clinical Trial

Phase 3 Clinical Trial

Biotechnology

RegeneRx Licensee to Expand Phase 3 Clinical Trial Program with RGN-259

PR Newswire - June 24, 2022

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting that its U.S. joint venture (JV) partner...

Biotechnology

PharmaMar and Jazz Pharmaceuticals Announce Initiation of Confirmatory Phase 3 Clinical Trial of Zepzelca® (lurbinectedin) for the Treatment of Patients with Relapsed Small Cell...

PR Newswire - December 14, 2021

PharmaMar and partner Jazz Pharmaceuticals plc announced the initiation of a confirmatory Phase 3 clinical trial, LAGOON, evaluating Zepzelca® (lurbinectedin) for the treatment of...